Liminatus Pharma, Inc. Warrants
$0.04
+0.00 (+0.00%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -8.5%
- 3 Months
- -27.9%
- YTD
- +14.3%
- 1 Year
- -67.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 377.4%
- Largest decline max drawdown, since May 2025
- -92.5%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.87
Own LIMNW?
See how LIMNW contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.